A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase

Journal of Neuroscience Methods

Volumn 161, Issue 1, 2007, Pages 47-54

  Kage, Karen L ^a   Richardson, Paul L ^a   Traphagen, Linda ^a   Severin, Jean ^a   Pereda Lopez, Ana ^a   Lubben, Thomas ^a   Davis Taber, Rachel ^a   Vos, Melissa H ^a   Bartley, Diane ^a   Walter, Karl ^a   Harlan, John ^a   Solomon, Larry ^a   Warrior, Usha ^a   Holzman, Thomas F ^a   Faltynek, Connie ^a   Surowy, Carol S ^a   Scott, Victoria E ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

FAAH; Fluorescent assay; High throughput screening

Indexed keywords

ANANDAMIDE; COUMARIN DERIVATIVE; DECANOIC ACID; DECANOYL 7 AMINO 4 METHYLCOUMARIN; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AMIDOHYDROLASES; AUTOMATION; BIOLOGICAL ASSAY; COUMARINS; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; REPRODUCIBILITY OF RESULTS;

EID: 33847670594     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.10.006     Document Type: Article

References (22)

1. Boger D.L., Sato H., Lerner A.E., Hedrick M.P., Fecik R.A., Miyauchi H., et al. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci USA 97 10 (2000) 5044-5049
2. Boger D.L., Miyauchi H., Du W., Hardouin C., Fecik R.A., Cheng H., et al. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J Med Chem 48 6 (2005) 1849-1856
3. Boldrup L., Wilson S.J., Barbier A.J., and Fowler C.J. A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J Biochem Biophys Methods 60 2 (2004) 171-177
4. Bracey M.H., Hanson M.A., Masuda K.R., Stevens R.C., and Cravatt B.F. Structural adaptations in the membrane enzyme that terminates endocannabinoid signaling. Science 298 29 (2002) 1793-1796
5. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., et al. Chemical characterization of a family of brain lipids that induce sleep. Science 268 5216 (1995) 1506-1509
6. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98 16 (2001) 9371-9376
7. De Bank P.A., Kendall D.A., and Alexander S.P.H. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. Biochem Pharmacol 69 8 (2005) 1187-1193
8. Deutsch D.G., and Chin S.A. Enzymatic synthesis and degradtionof anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46 5 (1993) 791-796
9. Fowler C.J., Jonsson K.O., and Tiger G. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. Biochem Pharmacol 62 5 (2001) 517-526
10. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102 51 (2005) 18620-18625
11. Jayamanne A., Greenwood R., Mitchell V.A., Aslan S., Piomelli D., and Vaughan C.W. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147 3 (2006) 281-288
12. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9 1 (2003) 76-81
13. Lichtman A.H., Leung D., Shelton C.C., Saghatelian A., Hardouin C., Boger D.L., et al. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311 2 (2004) 441-448
14. Maccarrone M., Bari M., and Agro A.F. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity. Anal Biochem 267 2 (1999) 314-318
15. Mor M., Rivara S., Lodola A., Plazzi P.V., Tarzia G., Duranti A., et al. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships and molecular modeling studies. J Med Chem 47 (2004) 4998-5008
16. Omeir R.L., Chin S., Hong Y., Ahern D.G., and Deutsch D.G. Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci 56 23-24 (1995) 1999-2005
17. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413 6855 (2001) 527-531
18. Patricelli M.P., Lashuel H.A., Giang D.K., Kelly J.W., and Cravatt B.F. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerication. Biochemistry 37 43 (1998) 15177-15187
19. Patricelli M.P., and Cravatt B.F. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Biochemistry 40 20 (2001) 6107-6115
20. Ramarao M.K., Murphy E.A., Shen M.W., Wang Y., Bushell K.N., Huang N., et al. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening. Anal Biochem 343 1 (2005) 143-151
21. Sheets M.P., Warrior U.P., Yoon H., Mollison K.W., Djuric S.W., and Trevillyan J.M. A high-capacity scintillation proximity assay for the discovery and evaluation of ZAP-70 tandem SH2 domain antagonists. J Biomol Screen 3 (1998) 139-144
22. Wilson S.J., Lovenberg T.W., and Barbier A.J. A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase. Anal Biochem 318 2 (2003) 270-275